Development of a Pediatric Relative Bioavailability/Bioequivalence Database and Identification of Putative Risk Factors Associated With Evaluation of Pediatric Oral Products

Generally, bioequivalence (BE) studies of drug products for pediatric patients are conducted in adults due to ethical reasons. Given the lack of direct BE assessment in pediatric populations, the aim of this work is to develop a database of BE and relative bioavailability (relative BA) studies condu...

Descripción completa

Detalles Bibliográficos
Autores principales: Pawar, Gopal, Wu, Fang, Zhao, Liang, Fang, Lanyan, Burckart, Gilbert J., Feng, Kairui, Mousa, Youssef M., Naumann, Franci, Batchelor, Hannah K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060189/
https://www.ncbi.nlm.nih.gov/pubmed/33884497
http://dx.doi.org/10.1208/s12248-021-00592-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060189/
https://www.ncbi.nlm.nih.gov/pubmed/33884497
http://dx.doi.org/10.1208/s12248-021-00592-y

Ejemplares similares